ID   RPMI-1788
AC   CVCL_2710
AS   CVCL_7352
SY   RPMI 1788; RPMI1788; Roswell Park Memorial Institute 1788; GM02131; GM2131; GM02131A; GM17219
DR   BTO; BTO:0005255
DR   CLO; CLO_0008867
DR   CLO; CLO_0013924
DR   CLO; CLO_0031846
DR   CLO; CLO_0051022
DR   CLDB; cl4169
DR   CLDB; cl4170
DR   CLDB; cl4171
DR   ATCC; CCL-156
DR   BioSample; SAMN00807500
DR   BioSample; SAMN03471459
DR   BioSample; SAMN03472770
DR   CLS; 300318
DR   Coriell; GM02131
DR   Coriell; GM17219
DR   ECACC; 85112106
DR   GEO; GSM569533
DR   GEO; GSM596283
DR   GEO; GSM596643
DR   GEO; GSM924821
DR   IZSLER; BS CL 75
DR   JCRB; IFO50037
DR   JCRB; JCRB0035
DR   KCLB; 10156
DR   RCB; RCB1878
DR   TKG; TKG 0464
DR   Wikidata; Q54951168
RX   CelloPub=CLPUB00447;
RX   PubMed=62390;
RX   PubMed=305004;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4366935;
RX   PubMed=6160588;
RX   PubMed=8139288;
RX   PubMed=9290701;
RX   PubMed=11173916;
RX   PubMed=16260726;
RX   PubMed=20889555;
RX   PubMed=29892436;
RX   PubMed=29959025;
WW   http://www.cells-talk.com/index.php/page/copelibrary?key=RPMI%201788
CC   Part of: Genetic Testing Reference Material (GeT-RM) samples.
CC   Part of: Human variation panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01,33:01:01; B*07:06:01,14:01:01; C*08:02:01,15:05:02; DPA1*01:03:01,02:01:01; DPB1*45:01,124:01:NEW; DQA1*02:01:01,03:03:01; DQB1*02:02:01,03:02:01; DRB1*04:05:01,07:01:01; DRB4*01:01:01,01:03:01 (PubMed=29959025).
CC   HLA typing: A*02:01:01,09:01:01; B*07:06:01,14:01:01; C*08:02:01,15:05:02; DPB1*03:01:01G,21:01; DQA1*02:01:01,03:03:01; DQB1*02:02:01,03:02:01; DRB1*04:05:01,07:01:01 (CLS=300318).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: DNA methylation analysis.
CC   Discontinued: KCLB; 10156; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC; CLS; ECACC; JCRB; RCB; TKG
ST   Amelogenin: X (JCRB)
ST   Amelogenin: X,Y (ATCC; CLS; ECACC; RCB; TKG)
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 10,13
ST   D18S51: 15,17
ST   D21S11: 31,32.2
ST   D3S1358: 13,16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 12,13
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 31
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=62390; DOI=10.1111/j.1365-3083.1976.tb03029.x;
RA   Yount W.J., Utsinger P.D., Hutt L.M., Buchanan P.D., Korn J.H.,
RA   Fuller C.R., Logue M., Pagano J.S.;
RT   "Subpopulations of human lymphoblastoid cell lines. Correlation with
RT   the expression of surface receptors and content of Epstein-Barr virus
RT   genome.";
RL   Scand. J. Immunol. 5:795-810(1976).
//
RX   PubMed=305004; DOI=10.1038/271756a0;
RA   Kishimoto T., Hirano T., Kuritani T., Yamamura Y., Ralph P.,
RA   Good R.A.;
RT   "Induction of IgG production in human B lymphoblastoid cell lines with
RT   normal human T cells.";
RL   Nature 271:756-758(1978).
//
RX   PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0;
RA   Drexler H.G., Gaedicke G., Minowada J.;
RT   "Isoenzyme studies in human leukemia-lymphoma cell lines -- 1.
RT   carboxylic esterase.";
RL   Leuk. Res. 9:209-229(1985).
//
RX   PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1;
RA   Drexler H.G., Gaedicke G., Minowada J.;
RT   "Isoenzyme studies in human leukemia-lymphoma cell lines -- III.
RT   Beta-hexosaminidase (E.C. 3.2.1.30).";
RL   Leuk. Res. 9:549-559(1985).
//
RX   PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x;
RA   Drexler H.G., Gaedicke G., Minowada J.;
RT   "Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid
RT   phosphatase.";
RL   Leuk. Res. 9:537-548(1985).
//
RX   PubMed=4366935;
RA   Minowada J., Nonoyama M., Moore G.E., Rauch A.M., Pagano J.S.;
RT   "The presence of the Epstein-Barr viral genome in human lymphoblastoid
RT   B-cell lines and its absence in a myeloma cell line.";
RL   Cancer Res. 34:1898-1903(1974).
//
RX   PubMed=6160588; DOI=10.1073/pnas.77.10.5938;
RA   Pickering L.A., Kronenberg L.H., Stewart W.E. II;
RT   "Spontaneous production of human interferon.";
RL   Proc. Natl. Acad. Sci. U.S.A. 77:5938-5942(1980).
//
RX   PubMed=8139288; DOI=10.1016/0145-2126(94)90118-x;
RA   Sato S., Honma Y., Hozumi M., Hayashi Y., Matsuo Y., Shibata K.,
RA   Omura S., Hino K.-i., Tomoyasu S., Tsuruoka N.;
RT   "Effects of herbimycin A and its derivatives on growth and
RT   differentiation of Ph1-positive acute lymphoid leukemia cell lines.";
RL   Leuk. Res. 18:221-228(1994).
//
RX   PubMed=9290701; DOI=10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D;
RA   Jia L.-Q., Osada M., Ishioka C., Gamo M., Ikawa S., Suzuki T.,
RA   Shimodaira H., Niitani T., Kudo T., Akiyama M., Kimura N., Matsuo M.,
RA   Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.;
RT   "Screening the p53 status of human cell lines using a yeast functional
RT   assay.";
RL   Mol. Carcinog. 19:243-253(1997).
//
RX   PubMed=11173916; DOI=10.1159/000051917;
RA   Hayashi T., Takahashi T., Motoya S., Ishida T., Itoh F., Adachi M.,
RA   Hinoda Y., Imai K.;
RT   "MUC1 mucin core protein binds to the domain 1 of ICAM-1.";
RL   Digestion 63 Suppl. 1:87-92(2001).
//
RX   PubMed=16260726; DOI=10.1073/pnas.0508390102;
RA   Harris S.L., Gil G., Robins H., Hu W.-W., Hirshfield K.M., Bond E.,
RA   Bond G., Levine A.J.;
RT   "Detection of functional single-nucleotide polymorphisms that affect
RT   apoptosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:16297-16302(2005).
//
RX   PubMed=20889555; DOI=10.2353/jmoldx.2010.100090;
RA   Pratt V.M., Zehnbauer B.A., Wilson J.A., Epstein-Baak R., Babic N.,
RA   Bettinotti M.P., Buller-Burckle A.M., Butz K.G., Campbell M.,
RA   Civalier C., El-Badry A., Farkas D.H., Lyon E., Mandal S., McKinney J.,
RA   Muralidharan K., Noll L., Sander T., Shabbeer J., Smith C.-Y.H.,
RA   Telatar M., Toji L.H., Vairavan A., Vance C., Weck K.E., Wu A.H.B.,
RA   Yeo K.-T.J., Zeller M., Kalman L.V.;
RT   "Characterization of 107 genomic DNA reference materials for CYP2D6,
RT   CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for
RT   Molecular Pathology collaborative project.";
RL   J. Mol. Diagn. 12:835-846(2010).
//
RX   PubMed=29892436; DOI=10.1098/rsos.172472;
RA   Shioda S., Kasai F., Watanabe K., Kawakami K., Ohtani A., Iemura M.,
RA   Ozawa M., Arakawa A., Hirayama N., Kawaguchi E., Tano T., Miyata S.,
RA   Satoh M., Shimizu N., Kohara A.;
RT   "Screening for 15 pathogenic viruses in human cell lines registered at
RT   the JCRB Cell Bank: characterization of in vitro human cells by viral
RT   infection.";
RL   R. Soc. Open Sci. 5:172472-172472(2018).
//
RX   PubMed=29959025; DOI=10.1016/j.jmoldx.2018.05.009;
RA   Bettinotti M.P., Ferriola D., Duke J.L., Mosbruger T.L., Tairis N.,
RA   Jennings L., Kalman L.V., Monos D.S.;
RT   "Characterization of 108 genomic DNA reference materials for 11 human
RT   leukocyte antigen loci: a GeT-RM collaborative project.";
RL   J. Mol. Diagn. 20:703-715(2018).
//